Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update.
作者信息
Gillot Constant, David Clara, Dogné Jean-Michel, Cabo Julien, Douxfils Jonathan, Favresse Julien
机构信息
Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium.
Research and Development Department, Qualiblood s.a., Namur, Belgium.
出版信息
Clin Chem Lab Med. 2024 Aug 16;63(3):e82-e85. doi: 10.1515/cclm-2024-0919. Print 2025 Feb 25.
PMID:39147380
Abstract
摘要
Zotero 插件